Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
Epetraborole by AN2 Therapeutics for Burkholderia pseudomallei Infections (Melioidosis): Likelihood of Approval
Epetraborole is under clinical development by AN2 Therapeutics and currently in Phase I for Burkholderia pseudomallei Infections (Melioidosis). According to...